SCHEMBL13638708

SCHEMBL13638708

Cc1ccc(S(=O)(=O)NC(=O)Nc2ccc(-n3c(C)nc4cc(N(C)C)ccc4c3=O)c(F)c2)s1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY12 Q9H244 1/20 0.40
GLA P06280 1/20 0.39
NOD1 Q9Y239 1/20 0.37
RAB9A P51151 2/20 0.36
PPARG P37231 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
NR2E3 Q9Y5X4 1/20 0.36
NCOR2 Q9Y618 1/20 0.36
IDO1 P14902 1/20 0.36
TDO2 P48775 1/20 0.36
IDO2 Q6ZQW0 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
HPD P32754 3/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
HCRTR1 O43613 2/20 0.34
HCRTR2 O43614 2/20 0.34
KDM4E B2RXH2 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9923200 0.93 P2RY12 (0.49) P2RY12GLANOD1RAB9APPARG
SCHEMBL12177329 0.89 P2RY12 (0.41) P2RY12GLANOD1RAB9APPARG
SCHEMBL12177247 0.89 GLA (0.52) P2RY12GLANOD1PPARGHPD
SCHEMBL14113579 0.88 P2RY12 (0.39) P2RY12GLANOD1PPARGMEN1
SCHEMBL13638511 0.88 P2RY12 (0.45) P2RY12NOD1RAB9APPARGRXFP1
SCHEMBL12177248 0.87 P2RY12 (0.40) P2RY12GLANOD1RAB9AMEN1
SCHEMBL9923210 0.87 P2RY12 (0.40) P2RY12GLANOD1PPARGMEN1
SCHEMBL13638586 0.87 P2RY12 (0.40) P2RY12GLANOD1RAB9APPARG
SCHEMBL13638710 0.86 P2RY12 (0.40) P2RY12GLANOD1RAB9APPARG
SCHEMBL9923204 0.85 P2RY12 (0.41) P2RY12GLANOD1RAB9APPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622474-B2 Asulfonyl(urea, thiourea, guanidine, cyanoguanidine) compounds; cardiovascular disorders; thrombosis PORTOLA PHARMACEUTICALS, INC. (US) 2009-11-24 US disclosed